Veritas Genetics
Latest round
- Series B
Last raised
- Oct 2016
Total raised
- $42M
Investors
- 2
About Veritas Genetics
Veritas Genetics Inc. provides advanced genetic testing services, focusing on whole exome and genome sequencing to deliver detailed insights into genetic information.Founded in 2014 and headquartered in Danvers, US, Veritas Genetics Inc. specializes in genetic testing services that encompass a range of diagnostics and preventive solutions. The company was founded by Mirza Cifric, who serves as the CEO. In November 2021, Veritas was acquired by PrivaPath Diagnostics Limited, marking a significant transition in its operational strategy.Veritas specializes in advanced genetic testing services, focusing on whole exome and genome sequencing to provide comprehensive insights into individual genetic information. Their core offerings include preventive medicine solutions that assess risks for common diseases, non-invasive prenatal testing for chromosomal abnormalities, and diagnostic genomics that evaluate hereditary conditions such as cardiovascular diseases and cancers. The company also provides a suite of personalized services, including myGenome, myGeneticRisk, and myHealthScore, which cater to different aspects of genetic healthcare management.Veritas generates revenue through a structured transactional model that includes direct-to-consumer sales and partnerships with healthcare providers. Their offerings are typically provided as one-time genetic testing services, each accompanied by mandatory genetic counseling sessions that facilitate the interpretation of results and the development of actionable healthcare plans. The firm focuses on a comprehensive pricing strategy that reflects the sophistication of its testing technologies and the expertise involved in analyzing genetic data. Their flagship products, such as myGenome and myPrenatal, are designed to deliver high clinical utility, ultimately enhancing the quality and longevity of life for users. The company aims to enhance its product line with new genetic testing offerings and plans to penetrate additional markets, specifically targeting expansion into Europe and Latin America by 2023. This strategic approach is designed to align with their vision of making genetic insights more accessible to consumers globally.
Who invested in Veritas Genetics
2 investors across 2 rounds
See all investors in Veritas Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Veritas Genetics
Who invested in Veritas Genetics?
Veritas Genetics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veritas Genetics raised?
Veritas Genetics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Veritas Genetics last raise money?
Veritas Genetics's most recent round on record is a Series B, in Oct 2016.
What does Veritas Genetics do?
Veritas Genetics is a healthcare company.
Where is Veritas Genetics headquartered?
Veritas Genetics is headquartered in Danvers, US.
Which VCs invest in companies like Veritas Genetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Veritas Genetics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Veritas Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.